BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jensen S, Seidelin JB, LaCasse EC, Nielsen OH. SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases. Sci Signal. 2020;13. [PMID: 32071170 DOI: 10.1126/scisignal.aax8295] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang N, Zhang WQ, Dong H, Hao YT, Zhang LM, Shan L, Yang XD, Peng CL. SMAC exhibits anti-tumor effects in ECA109 cells by regulating expression of inhibitor of apoptosis protein family. World J Clin Cases 2021; 9(19): 5019-5027 [PMID: 34307552 DOI: 10.12998/wjcc.v9.i19.5019] [Reference Citation Analysis]
2 Moen IN, Westhrin M, Håland E, Haug M, Nonstad U, Klaharn M, Standal T, Starheim KK. Smac-mimetics reduce numbers and viability of human osteoclasts. Cell Death Discov 2021;7:36. [PMID: 33608503 DOI: 10.1038/s41420-021-00415-1] [Reference Citation Analysis]
3 Wang C, Zhang Y, Wang J, Xing D. VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives. Eur J Med Chem 2022;227:113906. [PMID: 34656901 DOI: 10.1016/j.ejmech.2021.113906] [Reference Citation Analysis]
4 Jaafar RF, Ibrahim Z, Ataya K, Hassanieh J, Ard N, Faraj W. Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer. Medicina (Kaunas) 2021;57:709. [PMID: 34356990 DOI: 10.3390/medicina57070709] [Reference Citation Analysis]
5 Jiayong Z, Shengchen W, Xiaofang H, Gang S, Shiwen X. The antagonistic effect of selenium on lead-induced necroptosis via MAPK/NF-κB pathway and HSPs activation in the chicken spleen. Ecotoxicol Environ Saf 2020;204:111049. [PMID: 32758698 DOI: 10.1016/j.ecoenv.2020.111049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 LaCasse EC. Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? Cell Death Dis 2020;11:350. [PMID: 32393742 DOI: 10.1038/s41419-020-2533-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Silke J, O'Reilly LA. NF-κB and Pancreatic Cancer; Chapter and Verse. Cancers (Basel) 2021;13:4510. [PMID: 34572737 DOI: 10.3390/cancers13184510] [Reference Citation Analysis]
8 Patankar JV, Müller TM, Kantham S, Acera MG, Mascia F, Scheibe K, Mahapatro M, Heichler C, Yu Y, Li W, Ruder B, Günther C, Leppkes M, Mathew MJ, Wirtz S, Neufert C, Kühl AA, Paquette J, Jacobson K, Atreya R, Zundler S, Neurath MF, Young RN, Becker C. E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis. Nat Cell Biol 2021;23:796-807. [PMID: 34239062 DOI: 10.1038/s41556-021-00708-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Speir M, Djajawi TM, Conos SA, Tye H, Lawlor KE. Targeting RIP Kinases in Chronic Inflammatory Disease. Biomolecules 2021;11:646. [PMID: 33924766 DOI: 10.3390/biom11050646] [Reference Citation Analysis]
10 Liu S, Joshi K, Denning MF, Zhang J. RIPK3 signaling and its role in the pathogenesis of cancers. Cell Mol Life Sci 2021. [PMID: 34654937 DOI: 10.1007/s00018-021-03947-y] [Reference Citation Analysis]
11 Kist M, Vucic D. Cell death pathways: intricate connections and disease implications. EMBO J 2021;40:e106700. [PMID: 33439509 DOI: 10.15252/embj.2020106700] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
12 Wang C, Zhang Y, Shi L, Yang S, Chang J, Zhong Y, Li Q, Xing D. Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents. J Enzyme Inhib Med Chem 2022;37:1437-53. [PMID: 35589670 DOI: 10.1080/14756366.2022.2074414] [Reference Citation Analysis]
13 Liu L, Tang Z, Zeng Y, Liu Y, Zhou L, Yang S, Wang D. Role of necroptosis in infection-related, immune-mediated, and autoimmune skin diseases. J Dermatol 2021;48:1129-38. [PMID: 34109676 DOI: 10.1111/1346-8138.15929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li ZQ, Chen X, Wang Y. Small molecules targeting ubiquitination to control inflammatory diseases. Drug Discov Today 2021:S1359-6446(21)00216-6. [PMID: 33992766 DOI: 10.1016/j.drudis.2021.04.029] [Reference Citation Analysis]
15 Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T. Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis. Molecules 2020;25:E5439. [PMID: 33233619 DOI: 10.3390/molecules25225439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Samson AL, Garnish SE, Hildebrand JM, Murphy JM. Location, location, location: A compartmentalized view of TNF-induced necroptotic signaling. Sci Signal 2021;14:eabc6178. [PMID: 33531383 DOI: 10.1126/scisignal.abc6178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
17 Topal Y, Gyrd-hansen M. RIPK2 NODs to XIAP and IBD. Seminars in Cell & Developmental Biology 2021;109:144-50. [DOI: 10.1016/j.semcdb.2020.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 Kist M, Kőműves LG, Goncharov T, Dugger DL, Yu C, Roose-Girma M, Newton K, Webster JD, Vucic D. Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death. Cell Death Differ 2021;28:985-1000. [PMID: 32999468 DOI: 10.1038/s41418-020-00629-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Varfolomeev E, Goncharov T, Vucic D. Immunoblot Analysis of the Regulation of TNF Receptor Family-Induced NF-κB Signaling by c-IAP Proteins. Methods Mol Biol 2021;2366:109-23. [PMID: 34236635 DOI: 10.1007/978-1-0716-1669-7_7] [Reference Citation Analysis]
20 Webster JD, Vucic D. The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues. Front Cell Dev Biol 2020;8:365. [PMID: 32671059 DOI: 10.3389/fcell.2020.00365] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
21 Song S, Ding Y, Dai GL, Zhang Y, Xu MT, Shen JR, Chen TT, Chen Y, Meng GL. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation. Acta Pharmacol Sin 2021;42:230-41. [PMID: 32770173 DOI: 10.1038/s41401-020-0490-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]